Emami Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Emami Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $2.1M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Emami Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $2.1M Trade | TransData Nexus

Product Portfolio — Top 4 by Export Value

Emami Limited exports 4 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Herbal	Ayurvedic & Herbal Products	$1.2M	78	6.4%	2
2	Ayurvedic	Ayurvedic & Herbal Products	$731.1K	152	3.2%	7
3	Churna	Ayurvedic & Herbal Products	$135.5K	19	7.6%	4
4	Gutika	Ayurvedic & Herbal Products	$21.4K	6	17.1%	2

Emami Limited exports 4 pharmaceutical products across 1 therapeutic categories with a total export value of $2.1M. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Emami Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Emami Limited, established in 1974 by Radhe Shyam Agarwal and Radhe Shyam Goenka, is a prominent Indian multinational company specializing in personal care and healthcare products. Headquartered in Kolkata, West Bengal, the company operates under the Corporate Identification Number (CIN) L24246WB1995PLC073513. As of March 2026, Emami Limited employs approximately 3,217 individuals. The company's diverse portfolio includes over 550 products across more than 20 brands, with a significant focus on Ayurvedic formulations. In the fiscal year ending March 2025, Emami Limited reported a turnover of ₹3,809 crore, reflecting its robust market presence. The company's official website is www.emamiltd.in.

2Manufacturing Facilities

Emami Limited operates multiple manufacturing facilities across India, including units in Amingaon, Patnagar, Dongri, and Pacharia. These facilities are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP). Additionally, the Amingaon, Patnagar, Dongri, and Pacharia units hold ISO 14001 and ISO 18000 certifications, indicating adherence to environmental and occupational health and safety standards. The company also has an overseas manufacturing unit in Bangladesh, expanding its production capabilities and regional reach.

3Key Leadership

As of March 2026, Emami Limited's leadership includes:

Harsha V Agarwal: Vice Chairman and Managing Director
R.S. Goenka: Chairman
Mohan Goenka: Vice Chairman
N.H. Bhansali: Chief Financial Officer and Chief Executive Officer - Finance, Strategy, and Business Development
Gul Raj Bhatia: President - Health Care Division

These executives play pivotal roles in steering the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Emami Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Emami Limited's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not explicitly detailed in the available sources. The company's international footprint spans over 70 countries, including regions like SAARC, MENAP, Southeast Asia, Africa, Eastern Europe, and the CIS nations. However, specific regulatory approvals or market access statuses in the aforementioned countries are not provided in the available information.

2Emerging Markets

Emami Limited has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's products are available in over 70 countries, including regions such as SAARC, MENAP, Southeast Asia, Africa, Eastern Europe, and the CIS nations. While the company has a significant presence in these regions, specific details regarding WHO prequalification or other certifications enabling access to these markets are not provided in the available sources.

3Geographic Strategy

Emami Limited's geographic strategy demonstrates a diversified approach, with products available in over 70 countries, including regions such as SAARC, MENAP, Southeast Asia, Africa, Eastern Europe, and the CIS nations. This extensive international presence indicates a strategic focus on mitigating concentration risk by tapping into diverse markets. The company's emphasis on Ayurvedic formulations aligns with global health and wellness trends, positioning it favorably in various international markets.

Emami Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Emami Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history are not available in the provided sources. The company's international operations include a manufacturing unit in Bangladesh, expanding its production capabilities and regional reach. However, explicit information about FDA approvals or compliance is not detailed in the available data.

2WHO & EU GMP

Emami Limited's manufacturing units are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP). Additionally, the Amingaon, Patnagar, Dongri, and Pacharia units hold ISO 14001 and ISO 18000 certifications, indicating adherence to environmental and occupational health and safety standards. However, specific details regarding WHO prequalification or EU GMP certificates are not provided in the available sources.

3CDSCO & Indian Regulatory

Emami Limited's manufacturing units in India are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP). The Amingaon, Patnagar, Dongri, and Pacharia units also hold ISO 14001 and ISO 18000 certifications, indicating adherence to environmental and occupational health and safety standards. Specific details regarding approvals from the Central Drugs Standard Control Organisation (CDSCO) or state drug controllers are not explicitly mentioned in the available sources.

Emami Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Emami Limited operates in the personal care and healthcare sectors, competing with other FMCG companies such as Hindustan Unilever Limited, Dabur India Limited, and ITC Limited. While specific market share comparisons are not provided in the available sources, Emami's diverse portfolio of over 550 products across more than 20 brands, with a significant focus on Ayurvedic formulations, positions it uniquely in the market. The company's emphasis on natural and Ayurvedic formulations aligns with global health and wellness trends, providing a competitive edge in various international markets.

2Key Differentiators

Emami Limited's key differentiators include its extensive portfolio of over 550 products across more than 20 brands, with a significant focus on Ayurvedic formulations. The company's manufacturing units are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP), with additional ISO certifications indicating adherence to environmental and occupational health and safety standards. These factors contribute to Emami's strong market presence and consumer trust.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Emami Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Emami Limited's track record as a supplier is supported by its extensive portfolio of over 550 products across more than 20 brands, with a significant focus on Ayurvedic formulations. The company's manufacturing units are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP), with additional ISO certifications indicating adherence to environmental and occupational health and safety standards. These factors contribute to the company's reliability and consistency in delivering quality products.

2Certifications to Verify

Importers should verify the following certifications when considering Emami Limited as a supplier:

ISO 9001:2000 Certification: Indicates adherence to quality management standards.
Good Manufacturing Practices (GMP) Compliance: Ensures manufacturing processes meet industry standards.
ISO 14001 Certification: Demonstrates commitment to environmental management.

Frequently Asked Questions — Emami Limited

How many pharmaceutical products does Emami Limited export from India?

Emami Limited exports 4 pharmaceutical products across 1 therapeutic categories. The top exports are Herbal ($1.2M), Ayurvedic ($731.1K), Churna ($135.5K), Gutika ($21.4K). Total export value is $2.1M.

What is Emami Limited's total pharmaceutical export value?

Emami Limited's total pharmaceutical export value is $2.1M, based on 255 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Emami Limited cover?

Emami Limited exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 4 products).

Get Full Emami Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Emami Limited

Emami Limited — Export Portfolio & Destination Treemap

Who is Emami Limited? — Company Overview & Market Position

What Does Emami Limited Export? — Product Portfolio Analysis

Top Products by Export Value

Emami Limited Therapeutic Categories — 1 Specializations